These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 33331954

  • 1. miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study.
    Pełka K, Klicka K, Grzywa TM, Gondek A, Marczewska JM, Garbicz F, Szczepaniak K, Paskal W, Włodarski PK.
    Histochem Cell Biol; 2021 Mar; 155(3):423-433. PubMed ID: 33331954
    [Abstract] [Full Text] [Related]

  • 2. A circular RNA, circSMARCA5, inhibits prostate cancer proliferative, migrative, and invasive capabilities via the miR-181b-5p/miR-17-3p-TIMP3 axis.
    Xie X, Sun FK, Huang X, Wang CH, Dai J, Zhao JP, Fang C, He W.
    Aging (Albany NY); 2021 Aug 13; 13(15):19908-19919. PubMed ID: 34390329
    [Abstract] [Full Text] [Related]

  • 3. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
    Dülgeroğlu Y, Eroğlu O.
    Microrna; 2020 Aug 13; 9(4):303-309. PubMed ID: 33155933
    [Abstract] [Full Text] [Related]

  • 4. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.
    Ambrozkiewicz F, Karczmarski J, Kulecka M, Paziewska A, Cybulska M, Szymanski M, Dobruch J, Antoniewicz A, Mikula M, Ostrowski J.
    Biomed Res Int; 2020 Aug 13; 2020():9086829. PubMed ID: 32462034
    [Abstract] [Full Text] [Related]

  • 5. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N, Gharbi S, Korsching E, Tavallaei M, Einollahi B, Mowla SJ.
    Prostate; 2019 Jan 13; 79(1):88-95. PubMed ID: 30194772
    [Abstract] [Full Text] [Related]

  • 6. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H.
    Prostate; 2013 Jun 13; 73(8):827-34. PubMed ID: 23184537
    [Abstract] [Full Text] [Related]

  • 7. The Association of miR-let 7b and miR-548 with PTEN in Prostate Cancer.
    Saffari M, Ghaderian SMH, Omrani MD, Afsharpad M, Shankaie K, Samadaian N.
    Urol J; 2019 Jun 17; 16(3):267-273. PubMed ID: 30318571
    [Abstract] [Full Text] [Related]

  • 8. TIMP4 expression is regulated by miR-200b-3p in prostate cancer cells.
    Janiak M, Paskal W, Rak B, Garbicz F, Jarema R, Sikora K, Włodarski P.
    APMIS; 2017 Feb 17; 125(2):101-105. PubMed ID: 28028835
    [Abstract] [Full Text] [Related]

  • 9. Identification of miRNA signatures and their therapeutic potentials in prostate cancer.
    Karadag A, Ozen A, Ozkurt M, Can C, Bozgeyik I, Kabadere S, Uyar R.
    Mol Biol Rep; 2021 Jul 17; 48(7):5531-5539. PubMed ID: 34318435
    [Abstract] [Full Text] [Related]

  • 10. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
    Jin W, Fei X, Wang X, Chen F, Song Y.
    J Immunol Res; 2020 Jul 17; 2020():5873056. PubMed ID: 32455140
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value.
    Fahim SA, Abdullah MS, Espinoza-Sánchez NA, Hassan H, Ibrahim AM, Ahmed SH, Shakir G, Badawy MA, Zakhary NI, Greve B, El-Shinawi M, Götte M, Ibrahim SA.
    Biomolecules; 2020 Jul 16; 10(7):. PubMed ID: 32708601
    [Abstract] [Full Text] [Related]

  • 12. MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer.
    Pang C, Liu M, Fang W, Guo J, Zhang Z, Wu P, Zhang Y, Wang J.
    Cell Physiol Biochem; 2016 Jul 16; 39(3):1111-7. PubMed ID: 27562849
    [Abstract] [Full Text] [Related]

  • 13. Potential plasma microRNAs signature miR-190b-5p, miR-215-5p and miR-527 as non-invasive biomarkers for prostate cancer.
    Khan MM, Serajuddin M, Bharadwaj M.
    Biomarkers; 2023 Mar 16; 28(2):227-237. PubMed ID: 36644827
    [Abstract] [Full Text] [Related]

  • 14. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI, Morales-Montor JG, Rangel-Escareño C, Langley E, Peralta-Zaragoza O, Cruz Colin JL, Rodriguez-Dorantes M.
    Mol Med Rep; 2016 Jun 16; 13(6):4549-60. PubMed ID: 27081843
    [Abstract] [Full Text] [Related]

  • 15. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
    Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E.
    Onco Targets Ther; 2016 Jun 16; 9():7545-7553. PubMed ID: 28008272
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
    Guo Z, He C, Yang F, Qin L, Lu X, Wu J.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31481527
    [Abstract] [Full Text] [Related]

  • 17. Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia.
    Sancer O, Koşar PA, Tefebaşı MY, Ergün O, Demir M, Koşar A.
    Turk J Med Sci; 2022 Jun 30; 52(3):788-795. PubMed ID: 36326314
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of miR-148a-3p and miR-106a-5p as Biomarkers for Prostate Cancer: Pilot Study.
    Coman RA, Schitcu VH, Budisan L, Raduly L, Braicu C, Petrut B, Coman I, Berindan-Neagoe I, Al Hajjar N.
    Genes (Basel); 2024 May 04; 15(5):. PubMed ID: 38790213
    [Abstract] [Full Text] [Related]

  • 19. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P, Hart M, Backes C, Rheinheimer S, Keck B, Wullich B, Keller A, Meese E.
    Tumour Biol; 2016 Aug 04; 37(8):10177-85. PubMed ID: 26831660
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.
    He L, Yao H, Fan LH, Liu L, Qiu S, Li X, Gao JP, Hao CQ.
    Genet Mol Res; 2013 Apr 02; 12(2):1012-21. PubMed ID: 23613247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.